ChemoCentryx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ChemoCentryx and buy or sell other stocks, ETFs, and their options commission-free!About CCXI
ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer.
CEODavid M. Reese, MD
CEODavid M. Reese, MD
Employees—
Employees—
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded1996
Founded1996
Employees—
Employees—
CCXI Key Statistics
Market cap3.71B
Market cap3.71B
Price-Earnings ratio-27.56
Price-Earnings ratio-27.56
Dividend yield—
Dividend yield—
Average volume864.70K
Average volume864.70K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$52.00
52 Week high$52.00
52 Week low$14.95
52 Week low$14.95
Stock Snapshot
The current ChemoCentryx(CCXI) stock price is $51.99, with a market capitalization of 3.71B. The stock trades at a price-to-earnings (P/E) ratio of -27.56.
On 2025-11-09, ChemoCentryx(CCXI) stock opened at —, reached a high of —, and a low of —.
ChemoCentryx(CCXI) shares are trading with a volume of 0, against a daily average of 864.7K.
During the past year, ChemoCentryx(CCXI) stock moved between $14.95 at its lowest and $52.00 at its peak.
During the past year, ChemoCentryx(CCXI) stock moved between $14.95 at its lowest and $52.00 at its peak.
People also own
Based on the portfolios of people who own CCXI. This list is generated using Robinhood data, and it’s not a recommendation.